1.00 / AMA PRA Category 1 Credit(s)TM 1.00 / CE for Nurses 1.00 / CE for Nurse Practitioners (0.50 pharmacology credit)
Provided by Veritas Institute for Medical Education, Inc.
Supported by an educational grant from Bayer HealthCare Pharmaceuticals
Despite improvements in the safety and tolerability of Long Acting Reversible Contraceptives (LARCs), as well as current guideline recommendations, recent studies suggest that physician attitudes have been slow to change. Physicians' concerns regarding the use of LARCs may reduce patient counseling regarding this option, which in turn will limit a patient's knowledge regarding LARC use and safety and as a consequence result in underuse. These findings suggest that there is a significant unmet need for educational interventions targeting health providers concerning the safety of LARCs for young and nulliparous women which may play an important role in increasing access to LARCs for this population.
The intended audience for this activity consists of primary care physicians, OB/GYN, physician assistants, nurse practitioners, nurses, and other health care professionals who are in a position to address the contraceptive needs of young women.
Upon completion of this activity, participants should be able to:
Describe the rate of unintended pregnancy in the United States
Identify evidence-based guidelines about contraceptive eligibility criteria
Describe contraception counseling utilizing a shared decision making framework
Counsel patients about a range of contraception options including method initiation and management of common side effects
Discuss the safety and efficacy of long-acting reversible contraceptives (LARC) including IUDs and implants
List clinician and patient contraception related resources
Consider systems practices which can affect contraceptive initiation and continuation
Conflict Of Interest Disclosure Policy
In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
Dr. Susan E Rubin MD, MPH Associate Professor Clinical Family & Social Medicine Albert Einstein College of Medicine Bronx, New York
Dr. Rubin has nothing to disclose.
Planners' and Managers' Disclosures
The staff of Veritas Institute for Medical Education, Inc., has nothing to disclose.
The independent reviewers from CME Peer Review have no financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Veritas Institute for Medical Education, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Veritas Institute for Medical Education, Inc., designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
California Board of Registered Nursing (CBRN)
Veritas Institute for Medical Education, Inc., is approved by the California Board of Registered Nursing, Provider #CEP13986, for 1.00 Contact Hour.
CE for Nurse Practitioners
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
Veritas Institute for Medical Education, Inc., is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education (provider number: 040309). This program has been approved for 1.00 contact hour of continuing education (which includes 0.50 hours of pharmacology).
Participant: Please claim only the portion of this program that you attended/successfully completed.
Disclosure of Unlabeled Use
Participants are advised that this CME/CE activity will contain references to medication or medical device names which at present are not FDA-approved for Contraceptive use.
The opinions expressed in this activity are those of the presenters and do not necessarily reflect those of Veritas Institute for Medical Education, Inc., or Bayer HealthCare Pharmaceuticals.
This activity is provided free of charge to participants.
In order to receive credit, participants must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 75% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.